Establishment of and improvements to the smart factory at the GMP plant in Hoengseong

Conclusion of CRO agreement concerning BOTAONE Inj. with SINOCRO (China)

Awarded 2 Million Dollar Export Tower from the Korea International Trade Association

Won Special Award at the Gangwon Export Awards

Approval of the Investigational New Drug (IND) Application for BOTAONE Inj. 100 units (Phase 1 clinical trial in Korea)

Conclusion of a CRO agreement concerning GT-100 with CSSi (USA)

Acknowledgment of contribution to job creation in Hoengseong-gun, Gangwon-do Province

KGMP approval of Hoengseong Factory 1

Item approval of BOTAONE Inj. 100 units for export

Conclusion of an MOU on joint R&D with Seoul National University Dental Research Institution

Submission of application for item approval for export

Acquisition of Innobiz certification from the Ministry of SMEs and Startups

Founding of BOTA ONE, INC., an American subsidiary

Establishment of Genetox Labs

Conclusion of an MOU on joint R&D with Kineta (USA)

Acquisition of pharmaceutical manufacturing business license

Completion of construction of the Genetox GMP plant in Hoengseong

Completion of a non-clinical study on botulinum toxin

Conclusion of an MOU on joint R&D with CHA Bundang Medical Center

Commencement of construction of the Genetox GMP plant in Hoengseong

Investment from Hana Bank

Investment from Korea SMEs and Startups Agency

Conclusion of an agreement on a non-clinical study on botulinum toxin (QuBEST BIO)

Conclusion of an MOU with Gangwon-do Province and Hoengseong County

Registration of Clostridium botulinum with the Korea Centers for Disease Control and Prevention

Registration of manufacture of Clostridium botulinum with the Ministry of Trade, Industry and Energy

- Designation as Venture Business (Korea Technology Finance Corporation)

Registration of high-risk pathogen handling facility (BL2) with the Korea Centers for Disease Control and Prevention

Registration of Genetox R&D Department

Establishment of Genetox Inc.